Search

Search Constraints

You searched for: Author/Creator Sanz, Laura

Search Results

1. A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. (31st December 2023)

2. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity. Issue 1 (December 2018)

3. Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin. (2nd November 2019)

4. ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy. (2nd January 2018)

5. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay. (December 2015)

9. Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation. Issue 5 (24th February 2016)